Karim Bitar is Chief Executive Officer of Convatec Group plc. Convatec is a leading global medical technologies company focused on solutions for the management of chronic conditions, with leading market positions in advanced wound care, stoma care, continence care and infusion care. Convatec products and services provide a range of clinical and economic benefits including infection prevention, improved clinical outcomes and reduced total cost of care.
Previously, Karim was Chief Executive Officer of Genus plc, a leading agricultural biotechnology company. During his eight-year tenure, the company was transformed into a technology pioneer with leading global franchises in dairy, beef and pork genetics. Prior to this, Karim worked for over 15 years with Eli Lilly & Company and was President of Lilly Europe, Canada and Australia before joining Genus. An ex- McKinsey & Company consultant, he worked across Asia and in Europe and also held management roles at Johnson & Johnson and the Dow Chemical Company.
Karim has a Masters (Hons) in Business Administration, University of Michigan, Ross School of Business and a Bachelor of Science in Biochemistry, University of Wisconsin.